Literature DB >> 25303055

Distinct expression of cytokeratin, N-cadherin and CD133 in circulating tumor cells of metastatic breast cancer patients.

Carolin Bock1, Brigitte Rack, Jens Huober, Ulrich Andergassen, Udo Jeschke, Sophie Doisneau-Sixou.   

Abstract

AIM: Circulating tumor cells (CTCs) appear as potential candidates to predict the ability of breast tumors to metastasize. Moreover, epithelial-mesenchymal transition (EMT) and stem cell features are major mechanisms for metastasis. PATIENTS &
METHODS: Using a triple fluorescence technique, the expression of EMT (N-cadherin) and stem cell markers (CD133) was analyzed in CTCs detected via cytokeratin in blood samples from 26 metastatic breast cancer patients.
RESULTS: We detected CTCs in 100% of the patients (n = 831 CTCs). In total, 67% of the CTCs were N-cadherin and CD133 negative. Nonetheless, 87.8 and 57.6%, respectively, of the CTCs that expressed one marker coexpressed the other. Both double-negative and double-positive CTCs were present in more than 90% of the patients. Within the CTCs of each patient, we demonstrated striking heterogeneities of marker expressions, cell shapes, clusters and sizes.
CONCLUSION: These data outline the importance of characterizing CTCs, especially through stem cell and EMT markers.

Entities:  

Keywords:  CD133; EMT; N-cadherin; breast cancer; circulating tumor cells; stem cells

Mesh:

Substances:

Year:  2014        PMID: 25303055     DOI: 10.2217/fon.14.58

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  11 in total

1.  Association of early changes of circulating cancer stem-like cells with survival among patients with metastatic breast cancer.

Authors:  Pei-Hung Chang; Chun-Hui Lee; Tyler Min-Hsien Wu; Kun-Yun Yeh; Hung-Ming Wang; Wen-Kuan Huang; Sheng-Chieh Chan; Wen-Chi Chou; Feng-Che Kuan; Hsuan-Chih Kuo; Yung-Chia Kuo; Ching-Chih Hu; Jason Chia-Hsun Hsieh
Journal:  Ther Adv Med Oncol       Date:  2022-07-15       Impact factor: 5.485

Review 2.  Biology and clinical significance of circulating tumor cell subpopulations in lung cancer.

Authors:  Linda O'Flaherty; Harriet Wikman; Klaus Pantel
Journal:  Transl Lung Cancer Res       Date:  2017-08

3.  Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients.

Authors:  Andra Kuske; Tobias M Gorges; Pierre Tennstedt; Anne-Kathrin Tiebel; Raisa Pompe; Felix Preißer; Sandra Prues; Martine Mazel; Athina Markou; Evi Lianidou; Sven Peine; Catherine Alix-Panabières; Sabine Riethdorf; Burkhard Beyer; Thorsten Schlomm; Klaus Pantel
Journal:  Sci Rep       Date:  2016-12-21       Impact factor: 4.379

4.  Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic Patients.

Authors:  Xi Zhang; Simone Hofmann; Brigitte Rack; Nadia Harbeck; Udo Jeschke; Sophie Sixou
Journal:  Int J Mol Sci       Date:  2017-06-20       Impact factor: 5.923

Review 5.  Circulating Tumor Cells: From Theory to Nanotechnology-Based Detection.

Authors:  Yue Ming; Yuanyuan Li; Haiyan Xing; Minghe Luo; Ziwei Li; Jianhong Chen; Jingxin Mo; Sanjun Shi
Journal:  Front Pharmacol       Date:  2017-02-01       Impact factor: 5.810

6.  Microfluidic Isolation of Circulating Tumor Cells and Cancer Stem-Like Cells from Patients with Pancreatic Ductal Adenocarcinoma.

Authors:  Jose I Varillas; Jinling Zhang; Kangfu Chen; Isis I Barnes; Chen Liu; Thomas J George; Z Hugh Fan
Journal:  Theranostics       Date:  2019-02-20       Impact factor: 11.556

7.  Early detection of tumor cells in bone marrow and peripheral blood in a fast‑progressing gastric cancer model.

Authors:  Prerna Bali; Ivonne Lozano-Pope; Collin Pachow; Marygorret Obonyo
Journal:  Int J Oncol       Date:  2021-01-12       Impact factor: 5.650

Review 8.  Stem cell technology in breast cancer: current status and potential applications.

Authors:  Rena Chiotaki; Hara Polioudaki; Panayiotis A Theodoropoulos
Journal:  Stem Cells Cloning       Date:  2016-04-26

9.  Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer.

Authors:  Francesca Collina; Maurizio Di Bonito; Valeria Li Bergolis; Michelino De Laurentiis; Carlo Vitagliano; Margherita Cerrone; Francesco Nuzzo; Monica Cantile; Gerardo Botti
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

Review 10.  The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells.

Authors:  Alexandra C Kölbl; Udo Jeschke; Ulrich Andergassen
Journal:  Int J Mol Sci       Date:  2016-08-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.